慢性肾脏疾病风险评估:利用日本年度健康检查数据的回顾性研究结果

IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Chihaya Fukai, Shumpei Chiba, Takaaki Itoga, Gen Kobayashi, Kohei Kaku
{"title":"慢性肾脏疾病风险评估:利用日本年度健康检查数据的回顾性研究结果","authors":"Chihaya Fukai, Shumpei Chiba, Takaaki Itoga, Gen Kobayashi, Kohei Kaku","doi":"10.1111/dom.16390","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims/introduction: </strong>While studies on kidney disease (KD) in patients with severe metabolic syndrome (MetS) have been reported, research on undiagnosed MetS individuals is limited. This study aimed to investigate KD mechanisms in early MetS stages among Japanese individuals to establish accurate KD prediction models applicable to specific health guidance using annual health check-up (HC) data.</p><p><strong>Materials and methods: </strong>Cox regression analysis was conducted using the Kokuho Database including HC and claims data over the past 10 years. Survival time was defined as the period from the initial HC during the observation period until estimated glomerular filtration rate (eGFR) fell below the following cut-offs: 60 mL/min/1.73 m<sup>2</sup> chronic kindney disease (CKD) and 15 mL/min/1.73 m<sup>2</sup> (ESKD) for primary scenarios, 45 mL/min/1.73 m<sup>2</sup> (CKD Stage 3b) and 30 mL/min/1.73 m<sup>2</sup> (CKD Stage 4) for additional scenarios. Predictive factors included age, sex and serum creatinine, which are components of eGFR, and MetS factors as follows: body mass index (BMI), glycated haemoglobin A1c (HbA1c), triglycerides (TG) and systolic blood pressure (SBP).</p><p><strong>Results: </strong>Significant increases in hazard ratios (HRs) for BMI, HbA1c, TG and SBP were observed for primary and additional cut-offs. BMI, HbA1c and TG showed progressively stronger HR increases with advancing stages. The model for all scenarios demonstrated goodness of fit with the high C-statistics.</p><p><strong>Conclusions: </strong>This study highlights the necessity of a comprehensive evaluation of MetS factors in CKD risk assessment and shows the model using annual HC data can identify CKD progression effectively and accurately. A risk assessment approach considering multiple CKD stages will be crucial for early intervention and disease prevention strategies.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chronic kidney disease risk assessment: Findings from backward-looking study using annual health check-up data in Japan.\",\"authors\":\"Chihaya Fukai, Shumpei Chiba, Takaaki Itoga, Gen Kobayashi, Kohei Kaku\",\"doi\":\"10.1111/dom.16390\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims/introduction: </strong>While studies on kidney disease (KD) in patients with severe metabolic syndrome (MetS) have been reported, research on undiagnosed MetS individuals is limited. This study aimed to investigate KD mechanisms in early MetS stages among Japanese individuals to establish accurate KD prediction models applicable to specific health guidance using annual health check-up (HC) data.</p><p><strong>Materials and methods: </strong>Cox regression analysis was conducted using the Kokuho Database including HC and claims data over the past 10 years. Survival time was defined as the period from the initial HC during the observation period until estimated glomerular filtration rate (eGFR) fell below the following cut-offs: 60 mL/min/1.73 m<sup>2</sup> chronic kindney disease (CKD) and 15 mL/min/1.73 m<sup>2</sup> (ESKD) for primary scenarios, 45 mL/min/1.73 m<sup>2</sup> (CKD Stage 3b) and 30 mL/min/1.73 m<sup>2</sup> (CKD Stage 4) for additional scenarios. Predictive factors included age, sex and serum creatinine, which are components of eGFR, and MetS factors as follows: body mass index (BMI), glycated haemoglobin A1c (HbA1c), triglycerides (TG) and systolic blood pressure (SBP).</p><p><strong>Results: </strong>Significant increases in hazard ratios (HRs) for BMI, HbA1c, TG and SBP were observed for primary and additional cut-offs. BMI, HbA1c and TG showed progressively stronger HR increases with advancing stages. The model for all scenarios demonstrated goodness of fit with the high C-statistics.</p><p><strong>Conclusions: </strong>This study highlights the necessity of a comprehensive evaluation of MetS factors in CKD risk assessment and shows the model using annual HC data can identify CKD progression effectively and accurately. A risk assessment approach considering multiple CKD stages will be crucial for early intervention and disease prevention strategies.</p>\",\"PeriodicalId\":158,\"journal\":{\"name\":\"Diabetes, Obesity & Metabolism\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2025-04-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/dom.16390\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.16390","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的/简介:虽然对严重代谢综合征(MetS)患者肾脏疾病(KD)的研究已有报道,但对未确诊的MetS患者的研究有限。本研究旨在探讨日本人早期MetS的KD机制,以建立准确的KD预测模型,适用于使用年度健康检查(HC)数据的特定健康指导。材料和方法:使用Kokuho数据库,包括近10年的HC和理赔数据,进行Cox回归分析。生存时间定义为从观察期间的初始HC到估计肾小球滤过率(eGFR)低于以下截止值的时间:原发性慢性肾病(CKD) 60 mL/min/1.73 m2和15 mL/min/1.73 m2 (ESKD),其他情况45 mL/min/1.73 m2 (CKD 3b期)和30 mL/min/1.73 m2 (CKD 4期)。预测因素包括年龄、性别和血清肌酐(eGFR的组成部分),代谢当量因素如下:体重指数(BMI)、糖化血红蛋白A1c (HbA1c)、甘油三酯(TG)和收缩压(SBP)。结果:BMI、HbA1c、TG和收缩压的风险比(hr)在主要和额外的临界值中显著增加。BMI、HbA1c和TG随着病程的进展,HR的增加逐渐增强。所有情景的模型都显示出高c统计量的拟合优度。结论:本研究强调了在CKD风险评估中对MetS因素进行综合评估的必要性,并表明使用年度HC数据的模型可以有效准确地识别CKD进展。考虑多个CKD阶段的风险评估方法对于早期干预和疾病预防策略至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Chronic kidney disease risk assessment: Findings from backward-looking study using annual health check-up data in Japan.

Aims/introduction: While studies on kidney disease (KD) in patients with severe metabolic syndrome (MetS) have been reported, research on undiagnosed MetS individuals is limited. This study aimed to investigate KD mechanisms in early MetS stages among Japanese individuals to establish accurate KD prediction models applicable to specific health guidance using annual health check-up (HC) data.

Materials and methods: Cox regression analysis was conducted using the Kokuho Database including HC and claims data over the past 10 years. Survival time was defined as the period from the initial HC during the observation period until estimated glomerular filtration rate (eGFR) fell below the following cut-offs: 60 mL/min/1.73 m2 chronic kindney disease (CKD) and 15 mL/min/1.73 m2 (ESKD) for primary scenarios, 45 mL/min/1.73 m2 (CKD Stage 3b) and 30 mL/min/1.73 m2 (CKD Stage 4) for additional scenarios. Predictive factors included age, sex and serum creatinine, which are components of eGFR, and MetS factors as follows: body mass index (BMI), glycated haemoglobin A1c (HbA1c), triglycerides (TG) and systolic blood pressure (SBP).

Results: Significant increases in hazard ratios (HRs) for BMI, HbA1c, TG and SBP were observed for primary and additional cut-offs. BMI, HbA1c and TG showed progressively stronger HR increases with advancing stages. The model for all scenarios demonstrated goodness of fit with the high C-statistics.

Conclusions: This study highlights the necessity of a comprehensive evaluation of MetS factors in CKD risk assessment and shows the model using annual HC data can identify CKD progression effectively and accurately. A risk assessment approach considering multiple CKD stages will be crucial for early intervention and disease prevention strategies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信